Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer-Reference-Cited by-同舟云学术

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Published:2009-05-20 Issue:10 Volume:101 Page:736-750
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cheang Maggie C. U.,Chia Stephen K.,Voduc David,Gao Dongxia,Leung Samuel,Snider Jacqueline,Watson Mark,Davies Sherri,Bernard Philip S.,Parker Joel S.,Perou Charles M.,Ellis Matthew J.,Nielsen Torsten O.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/101/10/736/18074850/djp082.pdf

Reference56 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

3. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci USA,2003

4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med.,2001

5. Tamoxifen for early breast canceran overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group;Lancet,1998

Cited by 1726 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Molecular Changes in Breast Cancer Induced by Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2024-10

3. Meme kanseri hücresi tanımlayan biyosensör;Ege Tıp Dergisi;2024-09-09

4. MRI radiomics and biological correlations for predicting axillary lymph node burden in early-stage breast cancer;Journal of Translational Medicine;2024-09-06

5. Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics;Cancer Medicine;2024-09